Takeda Pharmaceutical Co., Ltd. et al v. IMPAX Laboratories, Inc.
Filing
114
ORDER CONTINUING CASE MANAGEMENT CONFERENCE. Signed by Judge Lucy Koh on 10/29/14. (lhklc5S, COURT STAFF) (Filed on 10/29/2014)
1
2
3
4
5
UNITED STATES DISTRICT COURT
6
NORTHERN DISTRICT OF CALIFORNIA
7
SAN JOSE DIVISION
8
10
TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS U.S.A.,
INC., AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,
11
Plaintiffs,
United States District Court
For the Northern District of California
9
12
13
14
v.
IMPAX LABORATORIES, INC.,
Defendant.
)
)
)
)
)
)
)
)
)
)
)
)
)
Case No.:
13-CV-02416-LHK
ORDER CONTINUING CASE
MANAGEMENT CONFERENCE
15
16
In light of the Court’s order staying all deadlines for 45 days pending regulatory review of
17
the parties’ settlement (ECF No. 113), the case management conference set for November 5, 2014
18
is hereby CONTINUED to December 10, 2014, at 2:00 P.M., should it be necessary following the
19
regulatory review period.
20
IT IS SO ORDERED.
21
Dated: October 29, 2014
_________________________________
LUCY H. KOH
United States District Judge
22
23
24
25
26
27
28
1
Case Nos.: 13-CV-02416-LHK
ORDER CONTINUING CASE MANAGEMENT CONFERENCE
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?